Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Circ Res
2013 Jun 21;1131:22-31. doi: 10.1161/CIRCRESAHA.113.301324.
Show Gene links
Show Anatomy links
Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development.
Kang Y, Kim J, Anderson JP, Wu J, Gleim SR, Kundu RK, McLean DL, Kim JD, Park H, Jin SW, Hwa J, Quertermous T, Chun HJ.
???displayArticle.abstract???
The peptide ligand apelin and its receptor APJ constitute a signaling pathway with numerous effects on the cardiovascular system, including cardiovascular development in model organisms such as xenopus and zebrafish. This study aimed to characterize the embryonic lethal phenotype of the Apj-/- mice and to define the involved downstream signaling targets. We report the first characterization of the embryonic lethality of the Apj-/- mice. More than half of the expected Apj-/- embryos died in utero because of cardiovascular developmental defects. Those succumbing to early embryonic death had markedly deformed vasculature of the yolk sac and the embryo, as well as poorly looped hearts with aberrantly formed right ventricles and defective atrioventricular cushion formation. Apj-/- embryos surviving to later stages demonstrated incomplete vascular maturation because of a deficiency of vascular smooth muscle cells and impaired myocardial trabeculation and ventricular wall development. The molecular mechanism implicates a novel, noncanonical signaling pathway downstream of apelin-APJ involving Gα13, which induces histone deacetylase (HDAC) 4 and HDAC5 phosphorylation and cytoplasmic translocation, resulting in activation of myocyte enhancer factor 2. Apj-/- mice have greater endocardial Hdac4 and Hdac5 nuclear localization and reduced expression of the myocyte enhancer factor 2 (MEF2) transcriptional target Krüppel-like factor 2. We identify a number of commonly shared transcriptional targets among apelin-APJ, Gα13, and MEF2 in endothelial cells, which are significantly decreased in the Apj-/- embryos and endothelial cells. Our results demonstrate a novel role for apelin-APJ signaling as a potent regulator of endothelial MEF2 function in the developing cardiovascular system.
???displayArticle.pubmedLink???
23603510 ???displayArticle.pmcLink???PMC3739451 ???displayArticle.link???Circ Res ???displayArticle.grants???[+]
Chandra,
Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension.
2011, Pubmed
Chandra,
Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension.
2011,
Pubmed Charo,
Endogenous regulation of cardiovascular function by apelin-APJ.
2009,
Pubmed Cheng,
Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats.
2003,
Pubmed Chun,
Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis.
2008,
Pubmed Cox,
Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo.
2006,
Pubmed
,
Xenbase Devic,
Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ.
1999,
Pubmed
,
Xenbase Griffin,
A role for thrombin receptor signaling in endothelial cells during embryonic development.
2001,
Pubmed Inui,
Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis.
2006,
Pubmed
,
Xenbase Ishida,
Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo.
2004,
Pubmed Kälin,
Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis.
2007,
Pubmed
,
Xenbase Kawamata,
Molecular properties of apelin: tissue distribution and receptor binding.
2001,
Pubmed Kidoya,
Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis.
2008,
Pubmed Kim,
An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension.
2013,
Pubmed Kleinz,
Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells.
2005,
Pubmed Kleinz,
Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells.
2004,
Pubmed Kuba,
Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload.
2007,
Pubmed Lee,
Characterization of apelin, the ligand for the APJ receptor.
2000,
Pubmed Lin,
Requirement of the MADS-box transcription factor MEF2C for vascular development.
1998,
Pubmed Lin,
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C.
1997,
Pubmed Liu,
Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis.
2009,
Pubmed Loot,
A novel APJ signaling cascade that regulates cardiovascular development.
2013,
Pubmed Lu,
Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.
2000,
Pubmed Masri,
Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein.
2002,
Pubmed McKinsey,
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation.
2000,
Pubmed McLean,
Apelin/APJ signaling is a critical regulator of statin effects in vascular endothelial cells--brief report.
2012,
Pubmed Naya,
Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor.
2002,
Pubmed O'Dowd,
A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11.
1993,
Pubmed Offermanns,
Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency.
1997,
Pubmed Parmar,
Statins exert endothelial atheroprotective effects via the KLF2 transcription factor.
2005,
Pubmed Parmar,
Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2.
2006,
Pubmed Paskaradevan,
The Aplnr GPCR regulates myocardial progenitor development via a novel cell-non-autonomous, Gα(i/o) protein-independent pathway.
2012,
Pubmed Quertermous,
Apelin and its g protein-coupled receptor regulate cardiac development as well as cardiac function.
2007,
Pubmed Roberts,
Abnormal fluid homeostasis in apelin receptor knockout mice.
2009,
Pubmed Ruppel,
Essential role for Galpha13 in endothelial cells during embryonic development.
2005,
Pubmed Scimia,
APJ acts as a dual receptor in cardiac hypertrophy.
2012,
Pubmed Scott,
The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors.
2007,
Pubmed
,
Xenbase Sen-Banerjee,
Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells.
2005,
Pubmed Sheikh,
In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure.
2008,
Pubmed Sierro,
Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7.
2007,
Pubmed Sohn,
Transcriptional regulation of tissue-specific genes by the ERK5 mitogen-activated protein kinase.
2005,
Pubmed Szokodi,
Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.
2002,
Pubmed Tatemoto,
Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.
1998,
Pubmed Tatemoto,
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism.
2001,
Pubmed Wang,
Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS.
2010,
Pubmed Yu,
The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling.
2011,
Pubmed Zeng,
Apelin and its receptor control heart field formation during zebrafish gastrulation.
2007,
Pubmed
,
Xenbase
